LINEAGE CELL THERAPEUTICS IN

LCTX·53566P109·US·equity·Healthcare

Activist & Large Holder Filings

View all activist filings

No 13D/13G filings (>5% ownership) found for this stock.

Holders

$61.8M

Total Value

59%

Consensus

Avg Conviction

Data as of Q4 2025

|All HoldersSEC EDGAR Source

Institutional Intelligence62 institutional holders

Institutional Consensus

59%

% of active changes that are buys

Smart Money Flow

+16.9

Conviction-weighted net sentiment

Convergence

51/100

Institutional + insider + activist alignment

Avg Conviction

15/100

Average conviction score of holders

Institutional Score

46/100

Weak

Smart Money Convergence

51/100

Mixed Signals

Institutional (13F)

Insider (Form 4)

Activist (13D/13G)

Combines institutional (40%), insider (35%), and activist (25%) signals.

Recent Insider Trades

View all insider trades

No recent insider trades (SEC Form 4) found for LCTX.

Price History

Notable Holders

VANGUARD GROUP INC

$16.1M

COMERICA BANK

$7.7M

BlackRock, Inc.

$6.4M

Institutional Holders(Showing 5 of 62)

Filer	Action	Shares	Value	Portfolio Weight	Est. P&L	Conviction
VANGUARD GROUP INC	Increased	9.6M(+7.1%)	$16.1M	0.0%	+60.20%	30
COMERICA BANK	Unchanged	4.6M(0.0%)	$7.7M	0.0%	+128.08%	0
BlackRock, Inc.	Increased	3.8M(+71.9%)	$6.4M	0.0%	+66.79%	41
GEODE CAPITAL MANAGEMENT, LLC	Increased	2.5M(+1.7%)	$4.1M	0.0%	+19.32%	27
RENAISSANCE TECHNOLOGIES LLC	Increased	2.4M(+26.2%)	$4M	0.0%	+103.21%	33
Showing 5 of 62 results.PROUpgrade to see all →

LINEAGE CELL THERAPEUTICS IN

Activist & Large Holder Filings

Institutional Intelligence62 institutional holders

Recent Insider Trades

Notable Holders

Latest Activity2025-Q4

Continue exploring